Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7275 p665-671
15 November 2003

News summary

DIARY   Branch meetings   Future Events   Conferences

665 “We will address concerns over new contract,” Scottish pharmacists told Concerns raised by pharmacy contractors about the implementation of the Scottish pharmaceutical care strategy will be addressed during discussions on the new contract, participants in the Scottish Pharmaceutical General Council's first convention have been told ...more

665 Contractors approve new contract framework for England and Wales Community pharmacy contractors in England and Wales have voted by a large majority in support of the framework for the proposed new contract ...more

665 PSNC seeks meeting after 3.1 pc offer The Pharmaceutical Services Negotiating Committee is to seek an urgent meeting with Dr John Reid, the Secretary of State for Health, after receiving an offer of a 3.1 per cent increase in the global sum for 2003–04 ...more


AHA conference
Reports

666 Treat normotensive patients after MI or stroke with antihypertensives, too People with normal blood pressure should be given antihypertensives as part of a secondary prevention regimen in cardiovascular disease, according to Professor Richard Peto, University of Oxford ...more

666 Valsartan effective alternative to ACE inhibitors after heart attack Valsartan (Diovan), the angiotensin II receptor antagonist, is an effective alternative to angiotensin converting enzyme (ACE) inhibitors after heart attack, researchers report ...more

666 HRT coronary concerns explained Hormone replacement therapy may be beneficial in some women but harmful in others, said Richard Cannon, National Heart, Lung and Blood Institute, United States ...more

666 Fish oils not antiarrhythmic Fish oils do not have antiarrhythmic effects, research suggests ...more


Other news

667 Boots expands modernisation plans with new galley layout for dispensaries Boots The Chemists plans to refit all its dispensaries within the next three to four years as part of a modernisation programme in preparation for the introduction of the new pharmacy contracts ...more

667 New Boots boss slams poor past performance at pharmacy chain Richard Baker, the recently appointed chief executive of the Boots Co, has criticised the performance of the Boots The Chemists chain under its previous chief executive Steve Russell ...more

667 Boots starts trials of automation in stores Boots The Chemists has introduced automation to its branches at Newcastle and Oldham for trial periods ...more

667 Most returns are no longer required, Tesco scheme finds Almost half the medicines returned to Tesco instore pharmacies during a scheme run earlier this year were handed in because they were no longer required by patients ...more

668 Influenza season starts early this year Signs that the influenza season has started are beginning to emerge ...more

668 Lib Dems say medicines still over-used in care homes Most elderly people prescribed antipsychotic drugs in nursing homes are given the drugs inappropriately, according to a report published last week by Paul Burstow, Liberal Democrat Shadow Secretary of State for Health ...more

668 Industry has a role in response to terrorism, say MPs Better use should be made of the expertise of the pharmaceutical industry as part of the Government's anti-terrorism strategy, according to the House of Commons Select Committee on Science and Technology ...more

668 BANs to rINNs deadline extended The Medicines and Healthcare products Regulatory Agency is to extend the deadline for moving from using British Approved Names to recommended International Non-proprietary Names by three months to 30 June 2004 ...more

669 NPA Matrix — a discussion forum to support pharmaceutical manufacturers The National Pharmaceutical Association is to launch a discussion forum and support service for pharmaceutical manufacturers, called NPA Matrix ...more

669 Prices kept down, says the ABPI The National Health Service has benefited from medicines prices that, in real terms, are 12 per cent lower than a decade ago ...more

669 Former SSL and AAH executives charged with fraud Five former executives of SSL International and a former director of AAH Pharmaceuticals were charged with fraud on 5 November during an appearance at Macclesfield magistrates' court ...more

670 NHS Direct given good report by CHI NHS Direct, the National Health Service's 24-hour telephone helpline for England and Wales, provides good quality advice and reassurance and is appreciated by the people who use it. This is the conclusion of the Commission for Health Improvement in its first report on the service ...more

670 Pharmacists customise training programme for transplant patients Pharmacists at the Royal Free Hospital in London are customising a new training programme for transplant patients in a bid to reduce long-term graft rejection ...more

670 New single dose Levonelle regimen Levonelle, used for emergency hormonal contraception, has a new dosage regimen which is less likely to lead to contraception failure as a result of women forgetting to take the second dose after 12 hours ...more

670 NHS website relaunched The National Health Service gateway website for patients was officially relaunched by health minister John Hutton on 5 November ...more

671 Standard heart regimens reduce cardiovascular events by similar degree All the commonly used blood-pressure lowering regimens reduce the risk of total major cardiovascular events by a similar degree, an analysis of 29 trials published in The Lancet has revealed ...more

671 Out-of-hours health services get extra funding from DoH An additional £28m for the development of out-of-hours health services in England has been pledged by the Department of Health ...more

671 Casodex licence for localised prostate cancer withdrawn Patients being treated with Casodex 150mg (bicalutamide) for localised prostate cancer should be reviewed as soon as possible and have their treatment discontinued, says the Medicines and Healthcare products Regulatory Agency ...more

671 Potassium chloride reminder NHS trusts in England and Wales have been asked to tell the National Patient Safety Agency about any practical impediments to full implementation of new controls over the use of concentrated potassium chloride solutions ...more

671 Anastrozole benefit over tamoxifen The latest data to come from the ATAC (Arimidex, tamoxifen alone or in combination) study indicates that women treated with anastrozole (Arimidex) continue to remain free of breast cancer for longer than women treated with tamoxifen ...more

671 NICE consults on epilepsy drugs The National Institute for Clinical Excellence has published a Final Appraisal Determination on newer drugs for epilepsy in adults ...more

671 Tolerability of malaria prophylaxis Although generally well tolerated, combined chloroquine and proguanil is associated with more adverse events than other recommended malaria prophylaxis regimens ...more

671 Vitamin C reduces stroke risk Eating a diet rich in vitamin C appears to decrease a person's risk of stroke, particularly if they smoke, say researchers ...more

Back to Top

  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal